Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Reig Jofré Group in connection with the business acquisition of Bioglan AB
Mandate

Vinge advises Reig Jofré Group in connection with the business acquisition of Bioglan AB

September 07, 2009

Vinge has advised Reig Jofré Group in connection with the acquisition of the business of Bioglan AB from Midelfart Sonesson. Reig Joflé Group is one of the leading companies in Spain within the pharmaceuticals industry. Bioglan AB conducts operations in relation to contract development and manufacture of dermatological pharmaceuticals under the supervision of the Swedish Medical Products Agency.

Reig Jofré Group was advised by partner Peter Abrahamsson and associates Kristian Ford, Andreas Schöldström, Marcus Bergdahl, Anna Bjering and Anna Bergstrand.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025